Pedinol Pharmacal Inc., Valeant Pharmaceuticals deal

Valeant said it acquired Pedinol for less than 1.5X sales. Revenue for 2011 was about $18 million. Pedinol is a specialty pharma focusing on podiatry products. Valeant said the business would fit alon...